Cambridge biotech company earns international recognition as first trial patient receives treatment

SolasCure, a Cambridge-based biotech company developing revolutionary wound-cleaning technology, has seen its first trial patient receive…

New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

A new study has identified strains of gut microbiota that are associated with more severe strokes…

Evaluate report signals orphan drug market is niche no more

London, UK – 28 April 2022 – Evaluate, the leading provider of market intelligence and predictive…

R&D project by Cytosurge and the Swiss Federal Institute of Technology receives funding by Innosuisse

R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute…

Robert Hewitt: Are the business practices of commercial biospecimen brokers conducive to reliable and ethical biospecimen procurement?

Written by Robert Hewitt, Founder, Biosample Hub Just like any other business, the sourcing of biospecimens…

New MRI techniques pave way to predict multiple sclerosis disability

Research published in Brain1 has used new MRI techniques to show what is happening in the…

Low fat diets decrease testosterone levels in men

A new study conducted at the University of Worcester and published in The Journal of Steroid Biochemistry…

Blood test for depression, bipolar disorder offers promise of personalized treatment

Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime. While current…

Newcells Biotech secures over £5m for 3D tissue models

Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to…

Northampton General Hospital News: Recovery trial shows tocilizumab reduces deaths in patients hospitalised with COVID-19

Patients at Northampton General Hospital have been thanked for taking part in a research trial that…